(Q48100710)

8 February 2018

title

Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder (English)

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

16 June 2024

0 references

1 reference

Gavin P Reynolds

2

0 references

author name string

Lindsay M. Reynolds

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20684832

16 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20684832

16 June 2024

publication date

1 June 2010

1 reference

8 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0022395610001433?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

https://api.elsevier.com/content/article/PII:S0022395610001433?httpAccept=text/plain

16 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Journal of Psychiatric Research

16 June 2024

published in

1 reference

8 February 2018

volume

45

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

page(s)

54-59

1 reference

8 February 2018

Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Reversible decreases in N-acetylaspartate after acute brain injury

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Impaired emotional learning and reduced amygdala size in schizophrenia: a 3-month follow-up

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

16 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol

16 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

N-acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer's disease post-mortem brain tissue.

16 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.

16 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia.

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy

16 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Schizophrenia, temporal lobe epilepsy and psychosis: an in vivo magnetic resonance spectroscopy and imaging study of the hippocampus/amygdala complex

16 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression

16 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Immunohistochemical localization of N-acetylaspartate in rat brain

16 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

16 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

16 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia

16 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study

16 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia

16 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.

16 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Glutamate receptor dysfunction and schizophrenia

16 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors

16 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.

16 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Method to correlate 1H MRSI and 18FDG-PET.

16 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases

16 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Neuronal and glial metabolite content of the epileptogenic human hippocampus

16 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study

16 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

16 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage?

16 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder

16 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

The reduced neuropil hypothesis: a circuit based model of schizophrenia

16 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study

16 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Hippocampal atrophy in recurrent major depression

16 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

16 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

16 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

The stanley foundation brain collection and neuropathology consortium

16 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

16 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Single-voxel 1H PRESS at 4.0 T: precision and variability of measurements in anterior cingulate and hippocampus.

16 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia

16 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study

16 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings

16 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JPSYCHIRES.2010.05.001

16 June 2024

Identifiers

1 reference

8 February 2018

1 reference

8 February 2018